AdaptivCRT Algorithm Linked to Reduction in Readmissions

Share this content:
AdaptivCRT Algorithm Linked to Reduction in Readmissions
AdaptivCRT Algorithm Linked to Reduction in Readmissions

(HealthDay News) -- For patients with heart failure or all-cause index hospitalization, cardiac resynchronization therapy (CRT) devices equipped with the Medtronic AdaptivCRT (aCRT) algorithm correlate with a reduction in 30-day readmission, according to a study published online June 10 in JACC: Heart Failure.

Randall C. Starling, M.D., M.P.H., from the Cleveland Clinic, and colleagues examined the impact of aCRT on 30-day readmissions after heart failure and all-cause index hospitalizations using data from the Adaptive CRT trial. Patients were randomized to aCRT (318 patients) or CRT with echocardiographic-optimization (Echo; 160 patients). Patients were followed for a mean of 20.2 months. The proportion of heart failure and all-cause hospitalizations that had readmission within 30 days was compared.

The researchers found that the 30-day readmission rate was 19.1 percent in the aCRT group and 35.7 percent in the Echo group for heart failure (odds ratio, 0.41). The corresponding 30-day readmission rates were 14.8 versus 24.8 percent, for all-cause hospitalization (odds ratio, 0.54). Beyond 30 days there was also a significant reduction in the risk of readmission following heart failure or all-case index hospitalization with aCRT.

"aCRT is associated with a significant reduction in the probability of a 30-day readmission following both heart failure and all-cause hospitalizations," the authors write.

Several authors disclosed financial ties to Medtronic, which funded the study.

Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

Surveillance Frequency Doesn't Cut Mortality in Colorectal Cancer

Surveillance Frequency Doesn't Cut Mortality in Colorectal Cancer

And, intensity of imaging surveillance not linked to time to detection of colorectal cancer recurrence

Procalcitonin Assay Doesn't Cut Antibiotic Use in Lower RTI

Procalcitonin Assay Doesn't Cut Antibiotic Use in Lower ...

Provision of assay doesn't result in less antibiotic use for suspected lower respiratory tract infection

Preventing Child Maltreatment Not Yet Feasible in Primary Care

Preventing Child Maltreatment Not Yet Feasible in Primary ...

USPSTF says evidence inadequate for primary care interventions to prevent child maltreatment

is free, fast, and customized just for you!

Already a member?

Sign In Now »